title: Cytotoxicity evaluation of biodegradable Zn-3Mg alloy toward normal human osteoblast cells.
abstract: The recent proposal of using Zn-based alloys for biodegradable implants was not supported with sufficient toxicity data. This work, for the first time, presents a thorough cytotoxicity evaluation of Zn-3Mg alloy for biodegradable bone implants. Normal human osteoblast cells were exposed to the alloy's extract and three main cell-material interaction parameters: cell health, functionality and inflammatory response, were evaluated. Results showed that at the concentration of 0.75mg/ml alloy extract, cell viability was reduced by ~50% through an induction of apoptosis at day 1; however, cells were able to recover at days 3 and 7. Cytoskeletal changes were observed but without any significant DNA damage. The downregulation of alkaline phosphatase protein levels did not significantly affect the mineralization process of the cells. Significant differences of cyclooxygenase-2 and prostaglandin E2 inflammatory biomarkers were noticed, but not interleukin 1-beta, indicating that the cells underwent a healing process after exposure to the alloy. Detailed analysis on the cell-material interaction is further discussed in this paper.
authors: Faculty of Biosciences and Medical Engineering, Universiti Teknologi Malaysia, Johor Bahru, Malaysia.
authors: N S
authors: NS
authors: Murni
authors: Faculty of Biosciences and Medical Engineering, Universiti Teknologi Malaysia, Johor Bahru, Malaysia.
authors: M S
authors: MS
authors: Dambatta
authors: Institute of Bioscience, Universiti Putra Malaysia, Serdang, Malaysia.
authors: S K
authors: SK
authors: Yeap
authors: Institute of Medical Molecular Biotechnology, Universiti Teknologi MARA, Sungai Buloh, Malaysia.
authors: G R A
authors: GRA
authors: Froemming
authors: Faculty of Biosciences and Medical Engineering, Universiti Teknologi Malaysia, Johor Bahru, Malaysia; Dept. of Mining, Metallurgical and Materials Engineering & CHU de Québec Research Center, Laval University, Quebec City, Canada. Electronic address: hendra.hermawan@gmn.ulaval.ca.
authors: H
authors: H
authors: Hermawan
mesh_terms: D020341:Absorbable Implants; D000469:Alkaline Phosphatase / Q000378:metabolism; D000497:Alloys / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects; D001672:Biocompatible Materials / Q000494:pharmacology*; D015415:Biomarkers / Q000378:metabolism; D001842:Bone and Bones / Q000187:drug effects / Q000378:metabolism; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D051546:Cyclooxygenase 2 / Q000378:metabolism; D003599:Cytoskeleton / Q000187:drug effects / Q000378:metabolism; D004249:DNA Damage / Q000187:drug effects; D015232:Dinoprostone / Q000378:metabolism; D015536:Down-Regulation / Q000187:drug effects; D006801:Humans; D007249:Inflammation / Q000378:metabolism; D008274:Magnesium / Q000494:pharmacology*; D008422:Materials Testing / Q000379:methods; D010006:Osteoblasts / Q000187:drug effects* / Q000378:metabolism; D015032:Zinc / Q000494:pharmacology*
chemical_list: D000497:Alloys; D001672:Biocompatible Materials; D015415:Biomarkers; D051546:Cyclooxygenase 2; D000469:Alkaline Phosphatase; D008274:Magnesium; D015032:Zinc; D015232:Dinoprostone
keywords: Biodegradable metals; Cell–material interaction; Cytotoxicity; Osteoblast; Zinc